Showing results (191-200 of 349) with videos related to
Sort By:
Pageof 35
Journal of Neuropathology and Experimental Neurology|December 6, 2006
Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2Audrey Rousseau, Catherine L Nutt, Rebecca A Betensky, et al.Journal of Neuropathology and Experimental Neurology|September 1, 1995
Chromosome 19q deletions in human gliomas overlap telomeric to D19S219 and may target a 425 kb region centromeric to D19S112W H Yong, D Chou, K Ueki, et al.Journal of Neuropathology and Experimental Neurology|December 23, 1998
Loss of the NF2 gene and merlin occur by the tumorlet stage of schwannoma development in neurofibromatosis 2A O Stemmer-Rachamimov, Y Ino, Z Y Lim, et al.Acta Neuropathologica|January 1, 1993
Deletions on the long arm of chromosome 17 in pilocytic astrocytomaA von Deimling, D N Louis, A G Menon, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 22, 2014
Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of ciliaRobert T Jones, Malak S Abedalthagafi, Mohan Brahmandam, et al.Journal of Neuropathology and Experimental Neurology|January 1, 1995
Shared allelic losses on chromosomes 1p and 19q suggest a common origin of oligodendroglioma and oligoastrocytomaJ A Kraus, J Koopmann, P Kaskel, et al.Journal of the National Cancer Institute|December 17, 2011
Oncolytic virus-mediated manipulation of DNA damage responses: synergy with chemotherapy in killing glioblastoma stem cellsRyuichi Kanai, Samuel D Rabkin, Stephen Yip, et al.Journal of Neuropathology and Experimental Neurology|May 1, 1997
Meningioangiomatosis is associated with neurofibromatosis 2 but not with somatic alterations of the NF2 geneA O Stemmer-Rachamimov, M A Horgan, A L Taratuto, et al.The American Journal of Pathology|September 1, 1997
Molecular genetic analysis of giant cell glioblastomasB Meyer-Puttlitz, Y Hayashi, A Waha, et al.Journal of Neuro-Oncology|July 16, 2016
Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying)Quinn T Ostrom, Haley Gittleman, Carol Kruchko, et al.Pageof 35